A10532 Summary:

BILL NOA10532A
 
SAME ASSAME AS S07306-B
 
SPONSORRules (Morelle)
 
COSPNSRAbinanti, Peoples-Stokes, Barclay, Simanowitz, Cymbrowitz, Hevesi, Moya, Latimer, Pretlow, Quart, Lavine
 
MLTSPNSR
 
Amd S1410, Ins L
 
Relates to derivative transactions and over the counter derivative instruments.
Go to top    

A10532 Actions:

BILL NOA10532A
 
06/04/2012referred to insurance
06/14/2012reported referred to rules
06/15/2012amend and recommit to rules 10532a
06/18/2012reported
06/18/2012rules report cal.333
06/18/2012ordered to third reading rules cal.333
06/18/2012passed assembly
06/18/2012delivered to senate
06/18/2012REFERRED TO RULES
06/20/2012SUBSTITUTED FOR S7306B
06/20/20123RD READING CAL.998
06/20/2012PASSED SENATE
06/20/2012RETURNED TO ASSEMBLY
08/06/2012delivered to governor
08/17/2012signed chap.398
Go to top

A10532 Floor Votes:

DATE:06/18/2012Assembly Vote  YEA/NAY: 139/0
Yes
Abbate
Yes
Ceretto
Yes
Glick
Yes
Lentol
Yes
Murray
Yes
Ryan
Yes
Abinanti
Yes
Clark
ER
Goldfeder
Yes
Lifton
Yes
Nolan
Yes
Saladino
Yes
Amedore
Yes
Colton
Yes
Goodell
Yes
Linares
Yes
Oaks
Yes
Sayward
Yes
Arroyo
ER
Conte
Yes
Gottfried
Yes
Lopez PD
Yes
O'Donnell
Yes
Scarborough
Yes
Aubry
Yes
Cook
Yes
Graf
Yes
Lopez VJ
Yes
Ortiz
Yes
Schimel
Yes
Barclay
Yes
Corwin
Yes
Gunther
Yes
Losquadro
Yes
Palmesano
Yes
Schimminger
Yes
Barrett
Yes
Crespo
Yes
Hanna
Yes
Lupardo
Yes
Paulin
Yes
Simanowitz
AB
Barron
Yes
Crouch
Yes
Hawley
Yes
Magee
Yes
Peoples Stokes
Yes
Simotas
Yes
Benedetto
Yes
Curran
Yes
Heastie
Yes
Magnarelli
Yes
Perry
Yes
Skartados
Yes
Blankenbush
Yes
Cusick
ER
Hevesi
Yes
Maisel
Yes
Pretlow
Yes
Smardz
ER
Boyland
Yes
Cymbrowitz
Yes
Hikind
Yes
Malliotakis
Yes
Quart
Yes
Stevenson
Yes
Boyle
Yes
DenDekker
Yes
Hooper
Yes
Markey
Yes
Ra
Yes
Sweeney
Yes
Braunstein
Yes
Dinowitz
Yes
Jacobs
Yes
Mayer
Yes
Rabbitt
Yes
Tedisco
Yes
Brennan
Yes
Duprey
Yes
Jaffee
Yes
McDonough
Yes
Raia
Yes
Tenney
Yes
Brindisi
Yes
Englebright
ER
Jeffries
Yes
McEneny
Yes
Ramos
Yes
Thiele
Yes
Bronson
Yes
Espinal
Yes
Johns
Yes
McKevitt
Yes
Reilich
Yes
Titone
Yes
Brook Krasny
Yes
Farrell
Yes
Jordan
Yes
McLaughlin
Yes
Reilly
ER
Titus
ER
Burling
Yes
Finch
Yes
Katz
ER
Meng
Yes
Rivera J
Yes
Tobacco
Yes
Butler
Yes
Fitzpatrick
Yes
Kavanagh
Yes
Miller D
Yes
Rivera N
Yes
Walter
Yes
Cahill
Yes
Friend
Yes
Kearns
ER
Miller JM
Yes
Rivera PM
Yes
Weinstein
Yes
Calhoun
Yes
Gabryszak
Yes
Kellner
Yes
Miller MG
Yes
Roberts
Yes
Weisenberg
Yes
Camara
Yes
Galef
Yes
Kolb
Yes
Millman
Yes
Robinson
Yes
Weprin
Yes
Canestrari
Yes
Gantt
ER
Lancman
Yes
Montesano
Yes
Rodriguez
Yes
Wright
Yes
Castelli
Yes
Gibson
Yes
Latimer
Yes
Morelle
Yes
Rosenthal
Yes
Zebrowski
Yes
Castro
Yes
Giglio
Yes
Lavine
Yes
Moya
Yes
Russell
Yes
Mr. Speaker

‡ Indicates voting via videoconference
Go to top

A10532 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                        10532--A
 
                   IN ASSEMBLY
 
                                      June 4, 2012
                                       ___________
 
        Introduced  by COMMITTEE ON RULES -- (at request of M. of A. Morelle) --
          read once and referred to the Committee on Insurance --  reported  and
          referred to the Committee on Rules -- Rules Committee discharged, bill
          amended, ordered reprinted as amended and recommitted to the Committee
          on Rules
 
        AN  ACT  to  amend  the  insurance law, in relation to derivative trans-

          actions and derivative instruments
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.    Subsection (f) of section 1410 of the insurance law, as
     2  added by chapter 650 of the laws of 1998, is amended to read as follows:
     3    (f)(1) The counterparty exposure under [a] an over the counter deriva-
     4  tive instrument entered into by an insurer authorized to engage in tran-
     5  sactions pursuant to this section shall be deemed to be an obligation of
     6  the institution to which the insurer is exposed to credit risk and shall
     7  be included in determining compliance with any single or aggregate quan-
     8  titative limitation on investments made by an insurer under  this  chap-
     9  ter.
    10    (2) Notwithstanding any single or aggregate quantitative limitation on

    11  investments  made  by an insurer under this chapter, an insurer may only
    12  transact an over the counter derivative instrument with:
    13    (A) a qualified counterparty; or
    14    (B) a counterparty other than a  "qualified  counterparty"  if,  after
    15  giving  effect  to that transaction, the aggregate counterparty exposure
    16  of the insurer under one or more over  the  counter  derivative  [trans-
    17  actions] instruments to:
    18    [(A)  any  single counterparty, other than a "qualified counterparty",
    19  shall be limited to one] (i) that non-qualified  counterparty  does  not
    20  exceed one percent of [an] the insurer's admitted assets; and

    21    [(B)]  (ii)  all  counterparties, other than qualified counterparties,
    22  [are limited to] does not exceed three percent  of  [an]  the  insurer's
    23  admitted assets.
    24    (3) For purposes of this section:
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD15578-05-2

        A. 10532--A                         2
 
     1    (A) a "qualified counterparty" is a ["qualified broker or dealer" or a
     2  "qualified  bank"  or  other  counterparty  rated AA-/Aa3 or higher by a
     3  nationally recognized statistical rating  organization  if  it  is  also
     4  approved by the superintendent;

     5    (B)  a  "qualified  broker or dealer" means a broker or dealer that is
     6  organized under the laws of a state and is registered under the  Securi-
     7  ties Exchange Act of 1934, 15 U.S.C. §§ 78a-78kk, and has net capital in
     8  excess of two hundred fifty million dollars;
     9    (C) a "qualified bank" means a bank or trust company that:
    10    (i) is organized and existing, or in the case of a branch or agency of
    11  a foreign banking organization is licensed, under the laws of the United
    12  States or any state thereof;
    13    (ii) is regulated, supervised and examined by United States federal or
    14  state  authorities  having  regulatory  authority  over  banks and trust
    15  companies;
    16    (iii) has assets in excess of five billion dollars;

    17    (iv) has senior obligations outstanding, or has a  parent  corporation
    18  that  has  senior  obligations  outstanding,  rated AA or better (or the
    19  equivalent thereto) by two independent nationally recognized statistical
    20  rating organizations; and
    21    (v) has a ratio of primary capital to total assets of  at  least  five
    22  and  one-half percent and a ratio of total capital to total assets of at
    23  least six percent; and
    24    (D)] counterparty which has an investment grade rating from  at  least
    25  one  nationally  recognized  statistical rating organization or a desig-
    26  nation of one from the Securities Valuation Office of the National Asso-
    27  ciation of Insurance Commissioners, or any successor office  established

    28  by  the  National Association of Insurance Commissioners, and with which
    29  the insurer has entered into a master agreement, together with a  credit
    30  support annex or other documentation providing for the collateralization
    31  of the counterparty's obligations to the insurer under the master agree-
    32  ment, if that collateral documentation provides for (i) daily margin and
    33  collateral  settlement,  in cash or investment grade securities, between
    34  the parties, (ii) a minimum transfer amount of no more than one  million
    35  dollars,  and  (iii)  a  requirement  that collateral be provided by the
    36  counterparty from the first dollar of exposure, subject to  the  minimum
    37  transfer amount;
    38    (B) "aggregate counterparty exposure" means the sum of: (i) the aggre-

    39  gate  statement  value of options, swaptions, caps, floors, and warrants
    40  purchased; and (ii) the aggregate potential exposure of collars,  swaps,
    41  forwards and futures entered into[.];
    42    (C)  "over  the  counter  derivative  instrument"  means  a derivative
    43  instrument which is authorized under this chapter other than  a  deriva-
    44  tive  instrument  (i) cleared through a United States or foreign deriva-
    45  tives clearinghouse, or (ii) traded on or through  a  United  States  or
    46  foreign exchange providing derivatives clearing services;
    47    (D) "derivatives clearinghouse" means a derivatives clearing organiza-
    48  tion  registered  with  the  Commodity Futures Trading Commission or the
    49  Securities and Exchange Commission  or,  if  not  so  registered,  is  a

    50  foreign clearinghouse regulated, supervised and examined by a regulatory
    51  authority in a foreign jurisdiction approved by the superintendent;
    52    (E)  "master  agreement"  means a written master agreement relating to
    53  derivatives transactions that provides for netting of payments  owed  by
    54  the respective parties, and the domiciliary jurisdiction of the counter-
    55  party  is  either  within  the United States or if not within the United

        A. 10532--A                         3
 
     1  States, within a jurisdiction approved by the superintendent as eligible
     2  for netting; and
     3    (F)  "minimum  transfer  amount"  means  an amount below which a daily
     4  margin and collateral settlement is not required.

     5    § 2. This act shall take effect immediately;  provided,  however  that
     6  the documentation requirements set forth in items (i), (ii) and (iii) of
     7  subparagraph  (A)  of paragraph (3) of subsection (f) of section 1410 of
     8  the insurance law as added by section one of this act shall take  effect
     9  on January 1, 2013.
Go to top